ARCADIS NV (ARCAD.AS)

NL0006237562 - Common Stock

63.85  -0.55 (-0.85%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ARCAD. ARCAD was compared to 30 industry peers in the Professional Services industry. ARCAD has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, ARCAD is valued expensive at the moment.



6

1. Profitability

1.1 Basic Checks

In the past year ARCAD was profitable.
In the past year ARCAD had a positive cash flow from operations.
In the past 5 years ARCAD has always been profitable.
ARCAD had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

ARCAD's Return On Assets of 4.95% is in line compared to the rest of the industry. ARCAD outperforms 44.83% of its industry peers.
ARCAD has a better Return On Equity (16.91%) than 62.07% of its industry peers.
ARCAD has a Return On Invested Capital (9.73%) which is in line with its industry peers.
ARCAD had an Average Return On Invested Capital over the past 3 years of 9.02%. This is below the industry average of 12.48%.
The 3 year average ROIC (9.02%) for ARCAD is below the current ROIC(9.73%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.95%
ROE 16.91%
ROIC 9.73%
ROA(3y)4.6%
ROA(5y)2.98%
ROE(3y)14.89%
ROE(5y)9.62%
ROIC(3y)9.02%
ROIC(5y)8.59%

1.3 Margins

ARCAD's Profit Margin of 5.02% is in line compared to the rest of the industry. ARCAD outperforms 55.17% of its industry peers.
ARCAD's Profit Margin has improved in the last couple of years.
ARCAD has a better Operating Margin (8.96%) than 68.97% of its industry peers.
In the last couple of years the Operating Margin of ARCAD has grown nicely.
Industry RankSector Rank
OM 8.96%
PM (TTM) 5.02%
GM N/A
OM growth 3Y0.26%
OM growth 5Y7.36%
PM growth 3Y77.81%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARCAD is creating some value.
Compared to 1 year ago, ARCAD has more shares outstanding
ARCAD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ARCAD has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.99 indicates that ARCAD is not a great score, but indicates only limited risk for bankruptcy at the moment.
ARCAD's Altman-Z score of 2.99 is in line compared to the rest of the industry. ARCAD outperforms 55.17% of its industry peers.
ARCAD has a debt to FCF ratio of 4.06. This is a neutral value as ARCAD would need 4.06 years to pay back of all of its debts.
The Debt to FCF ratio of ARCAD (4.06) is comparable to the rest of the industry.
ARCAD has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
ARCAD has a Debt to Equity ratio of 1.06. This is in the lower half of the industry: ARCAD underperforms 65.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 4.06
Altman-Z 2.99
ROIC/WACC1.47
WACC6.61%

2.3 Liquidity

A Current Ratio of 1.31 indicates that ARCAD should not have too much problems paying its short term obligations.
ARCAD has a Current ratio (1.31) which is comparable to the rest of the industry.
A Quick Ratio of 1.31 indicates that ARCAD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.31, ARCAD is in line with its industry, outperforming 58.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 67.56% over the past year.
The Earnings Per Share has been growing by 104.18% on average over the past years. This is a very strong growth
The Revenue has grown by 9.91% in the past year. This is quite good.
ARCAD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.03% yearly.
EPS 1Y (TTM)67.56%
EPS 3Y104.18%
EPS 5YN/A
EPS Q2Q%61.7%
Revenue 1Y (TTM)9.91%
Revenue growth 3Y14.66%
Revenue growth 5Y9.03%
Sales Q2Q%4.87%

3.2 Future

ARCAD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.30% yearly.
Based on estimates for the next years, ARCAD will show a small growth in Revenue. The Revenue will grow by 6.92% on average per year.
EPS Next Y18.84%
EPS Next 2Y18.99%
EPS Next 3Y17.98%
EPS Next 5Y17.3%
Revenue Next Year22.68%
Revenue Next 2Y14.32%
Revenue Next 3Y11.93%
Revenue Next 5Y6.92%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.98 indicates a quite expensive valuation of ARCAD.
Compared to the rest of the industry, the Price/Earnings ratio of ARCAD indicates a slightly more expensive valuation: ARCAD is more expensive than 65.52% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.62, ARCAD is valued at the same level.
A Price/Forward Earnings ratio of 17.01 indicates a rather expensive valuation of ARCAD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ARCAD is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ARCAD to the average of the S&P500 Index (21.22), we can say ARCAD is valued inline with the index average.
Industry RankSector Rank
PE 29.98
Fwd PE 17.01

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARCAD is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as ARCAD.
Industry RankSector Rank
P/FCF 18.21
EV/EBITDA 13.24

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ARCAD may justify a higher PE ratio.
ARCAD's earnings are expected to grow with 17.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.59
PEG (5Y)N/A
EPS Next 2Y18.99%
EPS Next 3Y17.98%

3

5. Dividend

5.1 Amount

ARCAD has a Yearly Dividend Yield of 1.32%. Purely for dividend investing, there may be better candidates out there.
ARCAD's Dividend Yield is slightly below the industry average, which is at 2.94.
Compared to an average S&P500 Dividend Yield of 2.26, ARCAD's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.32%

5.2 History

On average, the dividend of ARCAD grows each year by 35.08%, which is quite nice.
Dividend Growth(5Y)35.08%
Div Incr Years5
Div Non Decr Years5

5.3 Sustainability

ARCAD pays out 39.52% of its income as dividend. This is a sustainable payout ratio.
The dividend of ARCAD is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP39.52%
EPS Next 2Y18.99%
EPS Next 3Y17.98%

ARCADIS NV

AMS:ARCAD (9/6/2024, 7:00:00 PM)

63.85

-0.55 (-0.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.76B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.32%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 29.98
Fwd PE 17.01
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.95%
ROE 16.91%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.96%
PM (TTM) 5.02%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)67.56%
EPS 3Y104.18%
EPS 5Y
EPS Q2Q%
EPS Next Y18.84%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.91%
Revenue growth 3Y14.66%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y